Apimeds Pharmaceuticals Stock Jumps 43% Following Insurance Blockchain Deal

Key Facts

1Apimeds Pharmaceuticals stock jumped over 43% on Monday.

2Apimeds subsidiary MindWave signed a 2-year deal with BlockAssure to integrate blockchain technology into the insurance sector.

Apimeds Pharmaceuticals stock jumped over 43% on Monday, October 5, 2026. Benzinga reported that the surge followed an announcement from Apimeds subsidiary, MindWave, regarding a strategic two-year agreement with BlockAssure.

The partnership focuses on integrating blockchain technology into the insurance sector. The stock experienced significant bullish momentum as investors reacted to the commercial deal, which is viewed as a key growth driver for the company's digital and pharmaceutical interests.